A 7-residue peptide L-VAP (SNTRVAP) has a strong ability to bind to the GRP78 protein, which is often overexpressed on glioma, glioma stem cells, vasculogenic mimicry and neo vasculature. This evidence concerns the gene HSPA5 and central nervous system cancer.